import { TeachingSlideDeck } from '@/constants/types';

/**
 * Pre-quiz "Quick Teach" decks.
 *
 * Shown ONLY on a student's first attempt for a subsection (partId),
 * and automatically skipped for mastery quizzes.
 *
 * Authoring style (keep it short + scannable):
 * - Each fact should start with an emoji icon (ğŸ¯ ğŸ§¬ âš ï¸ ğŸš« ğŸ” âœ¨)
 * - Use the pattern "Label: info" to auto-bold the label.
 */
export const TEACHING_DECKS: Record<string, TeachingSlideDeck> = {
  // =========================
  // Module 1 â€” Cardiovascular I
  // =========================
  'm1-p2': {
    title: 'ACE Inhibitors & ARBs',
    slides: [
      {
        id: 'ace',
        emoji: 'ğŸ’–',
        title: 'ACE Inhibitors',
        subtitle: 'All ACE inhibitors end in -PRIL',
        facts: [
          'ğŸ¯ Use: HTN â€¢ HFrEF â€¢ postâ€‘MI â€¢ CKD/DM (â†“ proteinuria)',
          'ğŸ§¬ MOA: ACEâ†“ â†’ Ang IIâ†“ + Aldoâ†“ â†’ vasodilate + â†“Na/Hâ‚‚O',
          'âš ï¸ AEs: dry cough â€¢ hyperK â€¢ â†‘Cr â€¢ angioedema',
          'ğŸš« Avoid: pregnancy â€¢ hx angioedema â€¢ bilateral RAS',
          'ğŸ” Monitor: Kâº + SCr 1â€“2 wks after start/â†‘dose',
        ],
      },
      {
        id: 'arb',
        emoji: 'ğŸ’–',
        title: 'ARBs',
        subtitle: 'All ARBs end in -SARTAN',
        facts: [
          'ğŸ¯ Use: HTN â€¢ HFrEF â€¢ CKD/DM (ACEâ€‘cough alternative)',
          'ğŸ§¬ MOA: ATâ‚ block â†’ similar benefits; no bradykinin cough',
          'âš ï¸ AEs: hyperK â€¢ â†‘Cr â€¢ (rare) angioedema',
          'âœ¨ Pearl: usually NO dry cough',
          'ğŸš« Avoid: pregnancy; donâ€™t routine ACE+ARB (â†‘ AKI/hyperK)',
        ],
      },
    ],
  },

  'm1-p3': {
    title: 'Thiazide & Loop Diuretics',
    slides: [
      {
        id: 'thiazide',
        emoji: 'ğŸ’§',
        title: 'Thiazides',
        subtitle: 'HTN diuretic workhorse',
        facts: [
          'ğŸ¯ Use: HTN (firstâ€‘line) â€¢ mild edema',
          'ğŸ§¬ MOA: â†‘ Na/Cl excretion in DCT â†’ â†“ volume',
          'âš ï¸ AEs: hypoK â€¢ hypoNa â€¢ â†‘ uric acid â€¢ â†‘ glucose',
          'âœ¨ Pearl: chlorthalidone = longer acting than HCTZ',
          'ğŸš« Caution: gout; less effective when GFR is very low',
        ],
      },
      {
        id: 'loop',
        emoji: 'ğŸŒŠ',
        title: 'Loop Diuretics',
        subtitle: 'Big fluid offload (HF/edema)',
        facts: [
          'ğŸ¯ Use: edema/HF â€¢ pulmonary edema',
          'ğŸ§¬ MOA: blocks Naâ€‘Kâ€‘2Cl in Loop of Henle',
          'âš ï¸ AEs: hypoK â€¢ dehydration â€¢ ototoxicity â€¢ â†‘ uric acid',
          'âœ¨ Pearl: â€œloops lose CaÂ²âºâ€ (â†‘ Ca excretion)',
          'ğŸ” Monitor: Kâº/MgÂ²âº + volume status; consider supplements',
        ],
      },
    ],
  },

  'm1-p4': {
    title: 'Betaâ€‘Blockers (HTN, HF, CAD)',
    slides: [
      {
        id: 'bb-basics',
        emoji: 'ğŸ›¡ï¸',
        title: 'Betaâ€‘Blockers',
        subtitle: 'Most betaâ€‘blockers end in -LOL',
        facts: [
          'ğŸ¯ Use: HTN â€¢ angina â€¢ postâ€‘MI â€¢ rate control',
          'ğŸ§¬ MOA: Î² block â†’ â†“ HR/contractility + â†“ renin',
          'âš ï¸ AEs: bradycardia â€¢ fatigue â€¢ masks hypoglycemia',
          'ğŸš« Avoid: severe brady/heart block; caution asthma (nonâ€‘selective)',
          'âœ¨ Pearl: donâ€™t stop abruptly â†’ rebound tachy/angina',
        ],
      },
      {
        id: 'bb-hf',
        emoji: 'â¤ï¸â€ğŸ©¹',
        title: 'HF/CAD Pearls',
        subtitle: 'HFrEF â€œBB 3â€: carvedilol, metoprolol succinate, bisoprolol',
        facts: [
          'ğŸ¯ HFrEF: use â€œBB 3â€ + titrate slow (survivalâ†‘)',
          'âœ¨ Selective: metoprolol/atenolol/bisoprolol = Î²1â€‘selective',
          'âœ¨ Carvedilol: Î² + Î±1 block â†’ more BP drop',
          'âš ï¸ Watch: fluid retention early; adjust diuretic if needed',
          'ğŸ” Monitor: HR/BP; hold if symptomatic brady or shock',
        ],
      },
    ],
  },

  'm1-p5': {
    title: 'MRAs & ARNI',
    slides: [
      {
        id: 'mra',
        emoji: 'ğŸ§‚',
        title: 'MRAs (Kâ€‘Sparing)',
        subtitle: 'Spironolactone / Eplerenone',
        facts: [
          'ğŸ¯ Use: HFrEF (mortalityâ†“) â€¢ resistant HTN â€¢ ascites',
          'ğŸ§¬ MOA: aldosterone block â†’ Na/Hâ‚‚Oâ†“, Kâ†‘',
          'âš ï¸ AEs: hyperK â€¢ â†‘Cr',
          'âœ¨ Spiro pearl: gynecomastia; eplerenone less endocrine',
          'ğŸ” Monitor: Kâº + SCr (esp with ACE/ARB)',
        ],
      },
      {
        id: 'arni',
        emoji: 'ğŸ’–',
        title: 'ARNI',
        subtitle: 'Sacubitril/valsartan = ARNI',
        facts: [
          'ğŸ¯ Use: HFrEF (replaces ACE/ARB in stable patients)',
          'ğŸ§¬ MOA: neprilysin inhibit + ARB â†’ â†‘ natriuresis + â†“ Ang II',
          'âš ï¸ AEs: hypotension â€¢ hyperK â€¢ â†‘Cr â€¢ angioedema',
          'ğŸš« Avoid: pregnancy; hx angioedema; do NOT combine w/ACE',
          'âœ¨ Pearl: wait 36 hrs after stopping ACE before starting ARNI',
        ],
      },
    ],
  },

  'm1-p6': {
    title: 'Calcium Channel Blockers',
    slides: [
      {
        id: 'dhp',
        emoji: 'ğŸ©¸',
        title: 'DHP CCBs',
        subtitle: 'Most DHP CCBs end in -DIPINE',
        facts: [
          'ğŸ¯ Use: HTN â€¢ angina; good for Raynaudâ€™s',
          'ğŸ§¬ MOA: vasodilate (arterioles) â†’ â†“ BP',
          'âš ï¸ AEs: edema â€¢ flushing â€¢ headache â€¢ gingival hyperplasia',
          'âœ¨ Pearl: can cause reflex tachy (esp shortâ€‘acting)',
          'ğŸš« Caution: severe edema; avoid IR nifedipine',
        ],
      },
      {
        id: 'non-dhp',
        emoji: 'ğŸ’–',
        title: 'Nonâ€‘DHP CCBs',
        subtitle: 'Verapamil/Diltiazem = â€œrateâ€‘slowingâ€ CCBs',
        facts: [
          'ğŸ¯ Use: rate control (AF) â€¢ angina',
          'ğŸ§¬ MOA: â†“ AV node conduction â†’ â†“ HR',
          'âš ï¸ AEs: brady/heart block â€¢ constipation (verapamil)',
          'ğŸš« Avoid: HFrEF + with Î²â€‘blocker (heart block risk)',
          'âœ¨ Pearl: drug interactions (CYP3A4); monitor HR',
        ],
      },
    ],
  },

  // =========================
  // Module 2 â€” Cardiovascular II
  // =========================
  'm2-p1': {
    title: 'Statins (HMGâ€‘CoA Reductase Inhibitors)',
    slides: [
      {
        id: 'statins',
        emoji: 'ğŸ§ˆ',
        title: 'Statins',
        subtitle: 'All statins end in -STATIN',
        facts: [
          'ğŸ¯ Use: LDLâ†“ + ASCVD riskâ†“ (primary/secondary prevention)',
          'ğŸ§¬ MOA: HMGâ€‘CoA reductase inhibit â†’ â†‘ LDL receptors',
          'âš ï¸ AEs: myalgia/myopathy â€¢ rare rhabdo â€¢ â†‘ LFTs',
          'ğŸš« Avoid: pregnancy; caution active liver disease',
          'âœ¨ Pearl: CYP3A4 interactions (simva/atorva); take simva at night',
        ],
      },
    ],
  },

  'm2-p2': {
    title: 'Nonâ€‘Statin Lipid Agents',
    slides: [
      {
        id: 'ezetimibe',
        emoji: 'ğŸ§½',
        title: 'Ezetimibe',
        subtitle: 'Zetia = cholesterol absorption blocker',
        facts: [
          'ğŸ¯ Use: addâ€‘on to statin if LDL still high',
          'ğŸ§¬ MOA: blocks intestinal cholesterol uptake (NPC1L1)',
          'âš ï¸ AEs: diarrhea â€¢ â†‘ LFTs (with statin)',
          'âœ¨ Pearl: minimal systemic effects',
          'ğŸ” Monitor: lipids; LFTs if combined w/statin',
        ],
      },
      {
        id: 'tg-agents',
        emoji: 'ğŸŸ',
        title: 'Fibrates & Omegaâ€‘3s',
        subtitle: 'Fenofibrate / Icosapent ethyl (EPA)',
        facts: [
          'ğŸ¯ Use: high TGs (pancreatitis riskâ†“); EPA for CV risk in select',
          'ğŸ§¬ MOA: fibrates â†‘ LPL â†’ TGâ†“; EPA affects TG/VLDL',
          'âš ï¸ AEs: fibrates = myopathy (â†‘ w/statin) â€¢ gallstones',
          'âœ¨ Pearl: avoid gemfibrozil + statin; fenofibrate preferred',
          'ğŸ” Monitor: TG, LFTs; renal function for fenofibrate',
        ],
      },
      {
        id: 'pcsk9-niacin',
        emoji: 'ğŸ†',
        title: 'PCSK9 & Niacin',
        subtitle: 'PCSK9 inhibitors = big LDL drop',
        facts: [
          'ğŸ¯ Use: very highâ€‘risk ASCVD or familial hypercholesterolemia',
          'ğŸ§¬ MOA: PCSK9 inhibit â†’ â†‘ LDL receptors â†’ LDLâ†“â†“',
          'âš ï¸ AEs: injectionâ€‘site reactions; cost/adherence issues',
          'âš ï¸ Niacin AEs: flushing â€¢ hyperglycemia â€¢ hepatotoxicity',
          'âœ¨ Pearl: flushing â†“ with aspirin preâ€‘dose',
        ],
      },
    ],
  },

  'm2-p3': {
    title: 'Antiplatelets',
    slides: [
      {
        id: 'aspirin',
        emoji: 'ğŸ©¸',
        title: 'Aspirin',
        subtitle: 'Antiplatelet by COXâ€‘1 block',
        facts: [
          'ğŸ¯ Use: ACS/MI, stroke prevention (select patients)',
          'ğŸ§¬ MOA: irreversible COXâ€‘1 inhibit â†’ â†“ TXAâ‚‚',
          'âš ï¸ AEs: GI bleed â€¢ ulcer â€¢ bronchospasm (aspirin asthma)',
          'ğŸš« Avoid: active bleeding; kids w/viral illness (Reye risk)',
          'âœ¨ Pearl: 81 mg daily is standard antiplatelet dose',
        ],
      },
      {
        id: 'p2y12',
        emoji: 'ğŸ›‘',
        title: 'P2Y12 Inhibitors',
        subtitle: 'Clopidogrel/Prasugrel/Ticagrelor',
        facts: [
          'ğŸ¯ Use: DAPT after stent/ACS; clopidogrel alt for aspirin',
          'ğŸ§¬ MOA: block ADP (P2Y12) â†’ platelet activationâ†“',
          'âš ï¸ AEs: bleeding; ticagrelor = dyspnea/brady',
          'âœ¨ Pearl: clopidogrel is prodrug (CYP2C19) â€” avoid omeprazole',
          'ğŸš« Prasugrel avoid: prior stroke/TIA; caution age>75/low weight',
        ],
      },
    ],
  },

  'm2-p4': {
    title: 'Anticoagulants',
    slides: [
      {
        id: 'warfarin',
        emoji: 'ğŸ§¬',
        title: 'Warfarin',
        subtitle: 'Warfarin = INR + vitamin K',
        facts: [
          'ğŸ¯ Use: Afib, DVT/PE, mechanical valves (preferred)',
          'ğŸ§¬ MOA: inhibits vit K recycling â†’ â†“ II, VII, IX, X',
          'ğŸ” Monitor: INR (goal often 2â€“3); many drug/food interactions',
          'âš ï¸ AEs: bleeding; skin necrosis (rare); teratogenic',
          'âœ¨ Pearl: bridge w/heparin initially for acute clots',
        ],
      },
      {
        id: 'doacs',
        emoji: 'âš¡',
        title: 'DOACs',
        subtitle: 'â€œXABANâ€ = Xa, â€œGATRANâ€ = thrombin',
        facts: [
          'ğŸ¯ Use: Afib, DVT/PE (less monitoring than warfarin)',
          'ğŸ§¬ MOA: apix/riva = Xa inhibit; dabigatran = thrombin inhibit',
          'âš ï¸ AEs: bleeding; renal dose adjust',
          'âœ¨ Pearl: rapid onset (no bridge usually); fewer interactions',
          'ğŸš« Avoid: mechanical valves; caution severe renal impairment',
        ],
      },
      {
        id: 'heparins',
        emoji: 'ğŸ¥',
        title: 'Heparins',
        subtitle: 'Heparin/Enoxaparin = parenteral',
        facts: [
          'ğŸ¯ Use: acute DVT/PE, ACS, inpatient prophylaxis',
          'ğŸ§¬ MOA: activates antithrombin â†’ IIa/Xaâ†“ (LMWH mainly Xa)',
          'ğŸ” Monitor: aPTT for IV heparin; antiâ€‘Xa in special cases',
          'âš ï¸ AEs: bleeding; HIT; osteoporosis (long-term)',
          'âœ¨ Pearl: reversal = protamine (partial for LMWH)',
        ],
      },
    ],
  },

  'm2-p5': {
    title: 'Antianginals & Nitrates',
    slides: [
      {
        id: 'nitrates',
        emoji: 'ğŸ’¥',
        title: 'Nitrates',
        subtitle: 'Nitroglycerin = fast angina relief',
        facts: [
          'ğŸ¯ Use: acute angina (SL nitro); chronic angina (isosorbide)',
          'ğŸ§¬ MOA: NO donor â†’ venodilation â†’ â†“ preload/Oâ‚‚ demand',
          'âš ï¸ AEs: headache â€¢ hypotension â€¢ flushing',
          'ğŸš« NEVER mix: PDEâ€‘5 inhibitors (sildenafil) â†’ severe hypotension',
          'âœ¨ Pearl: nitrateâ€‘free interval daily to prevent tolerance',
        ],
      },
      {
        id: 'other-antianginals',
        emoji: 'ğŸ§©',
        title: 'Other Antianginals',
        subtitle: 'Ranolazine & rate/BP controllers',
        facts: [
          'ğŸ¯ CCBs/Î²â€‘blockers: chronic angina + BP/HR control',
          'ğŸ§¬ Ranolazine: alters Na current â†’ â†“ ischemia (HR/BP minimal)',
          'âš ï¸ Ranolazine AE: QT prolongation â€¢ CYP interactions',
          'âœ¨ Pearl: use when BP/HR limit other agents',
          'ğŸš« Avoid: severe liver disease; caution QT-prolonging meds',
        ],
      },
    ],
  },

  // =========================
  // Module 3 â€” Endocrine & Diabetes
  // =========================
  'm3-p1': {
    title: 'Insulin Overview (Basal & Bolus)',
    slides: [
      {
        id: 'basal',
        emoji: 'ğŸ©¸',
        title: 'Basal Insulin',
        subtitle: 'Steady â€œbackgroundâ€ control',
        facts: [
          'ğŸ¯ Use: fasting glucose control (T1 & T2)',
          'ğŸ§¬ Types: glargine/detemir/degludec = long; NPH = intermediate',
          'â±ï¸ Timing: once daily (some detemir BID); NPH often BID',
          'âš ï¸ AEs: hypoglycemia â€¢ weight gain',
          'âœ¨ Pearl: â€œTreat lowsâ€ rule â€” 15g carbs, recheck in 15 min',
        ],
      },
      {
        id: 'bolus',
        emoji: 'ğŸ½ï¸',
        title: 'Bolus / Prandial',
        subtitle: 'Meal + correction insulin',
        facts: [
          'ğŸ¯ Use: postâ€‘meal spikes + correction doses',
          'ğŸ§¬ Types: lispro/aspart = rapid; regular = short',
          'â±ï¸ Timing: rapid 0â€“15 min preâ€‘meal; regular ~30 min preâ€‘meal',
          'âš ï¸ AEs: hypoglycemia (esp if meal skipped)',
          'âœ¨ Pearl: sliding scale alone is weak â€” pair with basal',
        ],
      },
    ],
  },

  'm3-p2': {
    title: 'Metformin & Oral Agents Overview',
    slides: [
      {
        id: 'metformin',
        emoji: 'ğŸ¬',
        title: 'Metformin',
        subtitle: 'Firstâ€‘line T2DM (biguanide)',
        facts: [
          'ğŸ¯ Use: T2DM firstâ€‘line; weight neutral/â†“',
          'ğŸ§¬ MOA: â†“ hepatic gluconeogenesis + â†‘ insulin sensitivity',
          'âš ï¸ AEs: GI upset â€¢ B12 deficiency; rare lactic acidosis',
          'ğŸš« Hold/avoid: eGFR <30; contrast studies; severe hypoxia/sepsis',
          'âœ¨ Pearl: start low, titrate; take with meals',
        ],
      },
      {
        id: 'tzd',
        emoji: 'ğŸ§ˆ',
        title: 'TZDs (Pioglitazone)',
        subtitle: 'Insulin sensitivity boosters',
        facts: [
          'ğŸ¯ Use: T2DM; improves insulin resistance',
          'ğŸ§¬ MOA: PPARâ€‘Î³ agonist â†’ glucose uptakeâ†‘',
          'âš ï¸ AEs: weight gain â€¢ edema â€¢ HF exacerbation',
          'âš ï¸ Longâ€‘term: fractures; possible bladder CA signal',
          'ğŸš« Avoid: NYHA III/IV HF; caution liver disease',
        ],
      },
    ],
  },

  'm3-p3': {
    title: 'SGLT2 Inhibitors',
    slides: [
      {
        id: 'sglt2',
        emoji: 'ğŸš½',
        title: 'SGLT2 Inhibitors',
        subtitle: 'All SGLT2 inhibitors end in -FLOZIN',
        facts: [
          'ğŸ¯ Use: T2DM + big benefits in HF/CKD',
          'ğŸ§¬ MOA: blocks renal glucose reabsorption â†’ glucose in urine',
          'âš ï¸ AEs: genital yeast/UTI â€¢ volume depletion â€¢ euglycemic DKA',
          'ğŸš« Hold: surgery/acute illness; caution low BP or frequent UTIs',
          'âœ¨ Pearl: counsel hydration + sickâ€‘day rules',
        ],
      },
    ],
  },

  'm3-p4': {
    title: 'GLPâ€‘1, DPPâ€‘4, Sulfonylureas',
    slides: [
      {
        id: 'glp1',
        emoji: 'ğŸ¥—',
        title: 'GLPâ€‘1 Agonists',
        subtitle: 'Most GLPâ€‘1 agonists end in -TIDE',
        facts: [
          'ğŸ¯ Use: T2DM + weight loss; CV benefit in many',
          'ğŸ§¬ MOA: â†‘ insulin (glucoseâ€‘dependent) + slows gastric emptying',
          'âš ï¸ AEs: nausea/vomiting â€¢ pancreatitis (rare)',
          'ğŸš« Avoid: medullary thyroid CA/MEN2 (for many agents)',
          'âœ¨ Pearl: slow titration = less GI upset',
        ],
      },
      {
        id: 'dpp4',
        emoji: 'ğŸ§©',
        title: 'DPPâ€‘4 Inhibitors',
        subtitle: 'All DPPâ€‘4 inhibitors end in -GLIPTIN',
        facts: [
          'ğŸ¯ Use: modest A1c drop; weight neutral',
          'ğŸ§¬ MOA: â†‘ endogenous incretins â†’ insulinâ†‘, glucagonâ†“',
          'âš ï¸ AEs: pancreatitis (rare) â€¢ severe joint pain',
          'ğŸ” Dose: many require renal adjustment (except linagliptin)',
          'âœ¨ Pearl: low hypoglycemia risk unless combined w/SU/insulin',
        ],
      },
      {
        id: 'sulfonylurea',
        emoji: 'ğŸ­',
        title: 'Sulfonylureas',
        subtitle: 'â€œGLIâ€‘â€ drugs = insulin secretagogues',
        facts: [
          'ğŸ¯ Use: T2DM; inexpensive and effective',
          'ğŸ§¬ MOA: closes KATP in Î² cells â†’ insulin releaseâ†‘',
          'âš ï¸ AEs: hypoglycemia â€¢ weight gain',
          'ğŸš« Caution: elderly/renal disease (prolonged hypoglycemia)',
          'âœ¨ Pearl: glipizide safer in CKD vs glyburide',
        ],
      },
    ],
  },

  'm3-p5': {
    title: 'Thyroid Agents',
    slides: [
      {
        id: 'levothyroxine',
        emoji: 'ğŸ¦‹',
        title: 'Levothyroxine (T4)',
        subtitle: 'Take on empty stomach (consistent)',
        facts: [
          'ğŸ¯ Use: hypothyroidism',
          'ğŸ§¬ MOA: synthetic T4 â†’ converts to T3 in tissues',
          'â° How: take AM fasting; separate from Ca/Fe by 4 hrs',
          'ğŸ” Monitor: TSH every 6â€“8 wks after dose change',
          'âš ï¸ Too much: tremor â€¢ palpitations â€¢ weight loss',
        ],
      },
      {
        id: 'antithyroid',
        emoji: 'ğŸš«',
        title: 'Antithyroid Drugs',
        subtitle: 'Methimazole vs PTU',
        facts: [
          'ğŸ¯ Use: hyperthyroidism (Graves); PTU also thyroid storm',
          'ğŸ§¬ MOA: blocks TPO; PTU also blocks T4â†’T3',
          'âš ï¸ AEs: agranulocytosis (fever/sore throat!) â€¢ rash',
          'âš ï¸ PTU: hepatotoxic; methimazole teratogenic 1st trimester',
          'âœ¨ Pearl: PTU preferred in 1st trimester & thyroid storm',
        ],
      },
    ],
  },

  'm3-p6': {
    title: 'Adrenal Steroids (Systemic Corticosteroids)',
    slides: [
      {
        id: 'systemic-steroids',
        emoji: 'ğŸ§¯',
        title: 'Systemic Steroids',
        subtitle: 'â€œâ€‘SONE/â€‘SOLONEâ€ = corticosteroids',
        facts: [
          'ğŸ¯ Use: asthma/COPD flares, autoimmune, inflammation, cerebral edema',
          'ğŸ§¬ MOA: antiâ€‘inflammatory + immunosuppressive gene effects',
          'âš ï¸ AEs: hyperglycemia â€¢ mood changes â€¢ infection risk',
          'âš ï¸ Longâ€‘term: osteoporosis, cataracts, adrenal suppression',
          'âœ¨ Pearl: taper if prolonged use; give AM dose when possible',
        ],
      },
    ],
  },

  // =========================
  // Module 4 â€” CNS & Psych
  // =========================
  'm4-p1': {
    title: 'Antidepressants I (SSRIs, SNRIs)',
    slides: [
      {
        id: 'ssri',
        emoji: 'ğŸ˜Š',
        title: 'SSRIs',
        subtitle: 'Firstâ€‘line for depression/anxiety',
        facts: [
          'ğŸ¯ Use: MDD, GAD, OCD, PTSD',
          'ğŸ§¬ MOA: serotonin reuptake inhibit',
          'âš ï¸ AEs: GI upset â€¢ sexual dysfunction â€¢ insomnia',
          'âš ï¸ Risks: serotonin syndrome; withdrawal if abrupt stop',
          'âœ¨ Pearl: citalopram/escitalopram can prolong QT (doseâ€‘related)',
        ],
      },
      {
        id: 'snri',
        emoji: 'âš¡',
        title: 'SNRIs',
        subtitle: 'Also help neuropathic pain',
        facts: [
          'ğŸ¯ Use: depression/anxiety; chronic pain (duloxetine)',
          'ğŸ§¬ MOA: serotonin + norepi reuptake inhibit',
          'âš ï¸ AEs: â†‘ BP/HR â€¢ sweating â€¢ nausea',
          'ğŸš« Caution: uncontrolled HTN; taper to avoid withdrawal',
          'âœ¨ Pearl: watch serotonin syndrome with other serotonergics',
        ],
      },
    ],
  },

  'm4-p2': {
    title: 'Antidepressants II (TCAs, Atypicals)',
    slides: [
      {
        id: 'tca',
        emoji: 'ğŸ§ ',
        title: 'TCAs',
        subtitle: 'Strong but â€œsideâ€‘effect heavyâ€',
        facts: [
          'ğŸ¯ Use: depression; also neuropathic pain/migraine',
          'ğŸ§¬ MOA: inhibit NE/5â€‘HT reuptake + anticholinergic',
          'âš ï¸ AEs: dry mouth â€¢ constipation â€¢ urinary retention â€¢ sedation',
          'âš ï¸ Danger: overdose â†’ arrhythmias (wide QRS), seizures',
          'ğŸš« Avoid: high suicide risk; caution elderly',
        ],
      },
      {
        id: 'bupropion',
        emoji: 'ğŸš­',
        title: 'Bupropion',
        subtitle: 'Great when sexual SEs are an issue',
        facts: [
          'ğŸ¯ Use: depression; smoking cessation',
          'ğŸ§¬ MOA: NE/DA reuptake inhibit',
          'âœ¨ Pearl: minimal sexual dysfunction; weight neutral/â†“',
          'âš ï¸ AEs: insomnia â€¢ anxiety â€¢ seizure risk (doseâ€‘related)',
          'ğŸš« Avoid: seizure disorder; eating disorders',
        ],
      },
      {
        id: 'sleepy-atypicals',
        emoji: 'ğŸŒ™',
        title: 'Sleepy Atypicals',
        subtitle: 'Mirtazapine & trazodone (often nightly)',
        facts: [
          'ğŸ¯ Use: depression with insomnia; appetite issues (mirtazapine)',
          'âš ï¸ Mirtazapine: weight gain â€¢ sedation',
          'âš ï¸ Trazodone: sedation â€¢ orthostasis â€¢ priapism (rare)',
          'âœ¨ Pearl: trazodone is common â€œsleep addâ€‘onâ€ at low dose',
          'ğŸš« Caution: serotonin syndrome when combined w/other serotonergics',
        ],
      },
    ],
  },

  'm4-p3': {
    title: 'Antipsychotics (Typical & Atypical)',
    slides: [
      {
        id: 'atypical-antipsych',
        emoji: 'ğŸ§©',
        title: 'Atypical Antipsychotics',
        subtitle: 'Metabolic risk is the big tradeoff',
        facts: [
          'ğŸ¯ Use: schizophrenia, bipolar, adjunct depression',
          'ğŸ§¬ MOA: dopamine D2 block + serotonin effects (varies)',
          'âš ï¸ AEs: weight gain/metabolic syndrome (esp olanzapine)',
          'âš ï¸ Prolactin: â†‘ with risperidone; QT risk varies',
          'âœ¨ Pearl: aripiprazole = partial agonist â†’ less prolactin/weight',
        ],
      },
      {
        id: 'typical-eps',
        emoji: 'âš ï¸',
        title: 'Typical + EPS',
        subtitle: 'Haloperidol = high EPS risk',
        facts: [
          'ğŸ¯ Strong D2 block â†’ good for acute agitation/psychosis',
          'âš ï¸ EPS: dystonia, akathisia, parkinsonism, tardive dyskinesia',
          'âš ï¸ NMS: fever + rigidity + AMS + autonomic instability (emergency)',
          'ğŸ” Manage EPS: benztropine/diphenhydramine (acute dystonia)',
          'âœ¨ Pearl: monitor QT (haloperidol), especially IV',
        ],
      },
    ],
  },

  'm4-p4': {
    title: 'Anxiolytics & Sedatives',
    slides: [
      {
        id: 'benzos',
        emoji: 'ğŸ«§',
        title: 'Benzodiazepines',
        subtitle: 'Fast anxiety relief (shortâ€‘term)',
        facts: [
          'ğŸ¯ Use: acute anxiety, panic, seizures, alcohol withdrawal',
          'ğŸ§¬ MOA: â†‘ GABAâ€‘A frequency â†’ CNS depression',
          'âš ï¸ AEs: sedation â€¢ falls â€¢ dependence/tolerance',
          'ğŸš« Avoid: combine with opioids/alcohol (resp depression)',
          'âœ¨ Pearl: taper slowly; lorazepam safer in liver disease',
        ],
      },
      {
        id: 'sleep-aids',
        emoji: 'ğŸŒ™',
        title: 'Sleep Aids',
        subtitle: 'Zolpidem + nonâ€‘benzo options',
        facts: [
          'ğŸ¯ Zâ€‘drugs (zolpidem): insomnia (shortâ€‘term)',
          'âš ï¸ Zâ€‘drug AEs: sleep behaviors, nextâ€‘day sedation',
          'ğŸ¯ Hydroxyzine: anxiety/itch (sedating antihistamine)',
          'âš ï¸ Hydroxyzine: anticholinergic effects; QT risk',
          'âœ¨ Pearl: prioritize sleep hygiene; avoid chronic hypnotics',
        ],
      },
    ],
  },

  'm4-p5': {
    title: 'Stimulants & ADHD Meds',
    slides: [
      {
        id: 'stimulants',
        emoji: 'ğŸš€',
        title: 'Stimulants',
        subtitle: 'Amphetamines & methylphenidate',
        facts: [
          'ğŸ¯ Use: ADHD (firstâ€‘line); narcolepsy',
          'ğŸ§¬ MOA: â†‘ NE/DA in synapse (different mechanisms)',
          'âš ï¸ AEs: appetiteâ†“ â€¢ insomnia â€¢ â†‘ HR/BP â€¢ anxiety',
          'ğŸš« Caution: misuse risk, severe anxiety, uncontrolled HTN',
          'âœ¨ Pearl: monitor growth (kids), BP/HR; take early day',
        ],
      },
      {
        id: 'nonstimulants',
        emoji: 'ğŸ§©',
        title: 'Nonâ€‘Stimulants',
        subtitle: 'Atomoxetine + guanfacine',
        facts: [
          'ğŸ¯ Atomoxetine: ADHD when stimulants not ideal',
          'ğŸ§¬ MOA: NE reuptake inhibit',
          'âš ï¸ Atomoxetine: suicidality warning; rare liver injury',
          'ğŸ¯ Guanfacine: helps hyperactivity/impulsivity; helps tics',
          'âš ï¸ Guanfacine: sedation â€¢ hypotension; taper to avoid rebound',
        ],
      },
    ],
  },

  // =========================
  // Module 5 â€” Pain & Inflammation
  // =========================
  'm5-p1': {
    title: 'NSAIDs & Acetaminophen',
    slides: [
      {
        id: 'nsaids',
        emoji: 'ğŸ”¥',
        title: 'NSAIDs',
        subtitle: 'Antiâ€‘inflammatory pain relief',
        facts: [
          'ğŸ¯ Use: pain, fever, inflammation (arthritis)',
          'ğŸ§¬ MOA: COX inhibit â†’ prostaglandinsâ†“',
          'âš ï¸ AEs: GI bleed/ulcer â€¢ kidney injury â€¢ â†‘ BP',
          'âš ï¸ CV: higher risk with some (esp chronic/high dose)',
          'ğŸš« Avoid: active GI bleed; caution CKD & anticoagulants',
        ],
      },
      {
        id: 'acetaminophen',
        emoji: 'ğŸŒ¡ï¸',
        title: 'Acetaminophen',
        subtitle: 'Pain/fever (not strong inflammation)',
        facts: [
          'ğŸ¯ Use: pain + fever (weak antiâ€‘inflammatory)',
          'âš ï¸ Max: keep daily total â‰¤3â€“4 g (lower with liver disease/alcohol)',
          'âš ï¸ Toxicity: liver injury; early symptoms can be mild',
          'ğŸ§ª Antidote: Nâ€‘acetylcysteine (NAC) ASAP',
          'âœ¨ Pearl: combo products hide extra acetaminophen',
        ],
      },
    ],
  },

  'm5-p2': {
    title: 'Opioids & Pain Management',
    slides: [
      {
        id: 'opioid-basics',
        emoji: 'ğŸ’Š',
        title: 'Opioids (Basics)',
        subtitle: 'Pain relief with risk',
        facts: [
          'ğŸ¯ Use: moderateâ€‘severe acute pain; cancer pain',
          'ğŸ§¬ MOA: Î¼â€‘receptor agonism â†’ pain transmissionâ†“',
          'âš ï¸ AEs: constipation â€¢ nausea â€¢ sedation â€¢ resp depression',
          'ğŸš« Danger: combine with benzos/alcohol',
          'âœ¨ Pearl: start low, reassess; consider bowel regimen',
        ],
      },
      {
        id: 'tramadol',
        emoji: 'ğŸ§©',
        title: 'Tramadol',
        subtitle: 'Extra mechanisms â†’ extra interactions',
        facts: [
          'ğŸ§¬ Tramadol: weak Î¼ + SNRI effect',
          'âš ï¸ AEs: seizures (riskâ†‘) â€¢ serotonin syndrome',
          'ğŸš« Avoid: MAOIs/strong serotonergics when possible',
          'âœ¨ Pearl: not â€œsafeâ€ â€” still opioid + interaction heavy',
          'ğŸ” Watch: renal dose adjust; older adults = higher risk',
        ],
      },
      {
        id: 'naloxone',
        emoji: 'ğŸ›Ÿ',
        title: 'Naloxone (Rescue)',
        subtitle: 'Opioid reversal',
        facts: [
          'ğŸ¯ Use: suspected opioid overdose (slow/no breathing)',
          'ğŸ§¬ MOA: opioid receptor antagonist',
          'âš ï¸ Can precipitate: withdrawal (agitation, vomiting)',
          'âœ¨ Pearl: may need repeat doses (short halfâ€‘life)',
          'ğŸš« Always: call emergency services after use',
        ],
      },
    ],
  },

  'm5-p3': {
    title: 'Gout Medications',
    slides: [
      {
        id: 'acute-flare',
        emoji: 'ğŸ”¥',
        title: 'Treat Acute Flare',
        subtitle: 'Fast inflammation control',
        facts: [
          'ğŸ¯ Options: NSAIDs, colchicine, steroids',
          'ğŸ§¬ Colchicine: blocks microtubules â†’ neutrophilsâ†“',
          'âš ï¸ Colchicine AEs: diarrhea, myopathy (riskâ†‘ with statins)',
          'ğŸš« Caution: renal/hepatic impairment; CYP/Pâ€‘gp interactions',
          'âœ¨ Pearl: start early for best effect',
        ],
      },
      {
        id: 'urate-lowering',
        emoji: 'â¬‡ï¸',
        title: 'Urateâ€‘Lowering Therapy',
        subtitle: 'Allopurinol / Febuxostat',
        facts: [
          'ğŸ¯ Use: recurrent flares, tophi, kidney stones',
          'ğŸ§¬ MOA: xanthine oxidase inhibit â†’ uric acidâ†“',
          'âš ï¸ Allopurinol: hypersensitivity (HLAâ€‘B*58:01 risk)',
          'âš ï¸ Febuxostat: possible â†‘ CV mortality warning',
          'âœ¨ Pearl: start low + flare prophylaxis (colchicine/NSAID)',
        ],
      },
    ],
  },

  'm5-p4': {
    title: 'DMARDs & Biologics',
    slides: [
      {
        id: 'methotrexate',
        emoji: 'ğŸ§¬',
        title: 'Methotrexate',
        subtitle: 'Anchor DMARD for RA (weekly)',
        facts: [
          'ğŸ¯ Use: RA, psoriasis; weekly dosing',
          'ğŸ§¬ MOA: folate antagonist â†’ inflammationâ†“',
          'âš ï¸ AEs: mouth sores â€¢ GI â€¢ hepatotoxic â€¢ cytopenias',
          'ğŸš« Avoid: pregnancy; significant liver disease; alcohol excess',
          'âœ¨ Pearl: give folic acid; monitor CBC + LFTs',
        ],
      },
      {
        id: 'hydroxychloroquine',
        emoji: 'ğŸ‘ï¸',
        title: 'Hydroxychloroquine',
        subtitle: 'Gentler DMARD (eye monitoring)',
        facts: [
          'ğŸ¯ Use: RA, lupus; safeâ€‘ish in pregnancy',
          'ğŸ§¬ MOA: immune modulation (slow onset)',
          'âš ï¸ AEs: retinal toxicity (rare) â€¢ GI upset',
          'ğŸ” Monitor: baseline + periodic eye exams',
          'âœ¨ Pearl: onset takes weeks to months',
        ],
      },
      {
        id: 'tnf-inhibitors',
        emoji: 'ğŸ›¡ï¸',
        title: 'TNFâ€‘Î± Inhibitors',
        subtitle: 'Adalimumab / Etanercept',
        facts: [
          'ğŸ¯ Use: RA, IBD, psoriasis (biologic therapy)',
          'ğŸ§¬ MOA: blocks TNFâ€‘Î± â†’ inflammationâ†“',
          'âš ï¸ AEs: serious infections; reactivation TB/hepatitis',
          'ğŸ” Screen: TB + hepatitis before starting',
          'ğŸš« Avoid: live vaccines; caution HF & malignancy history',
        ],
      },
    ],
  },

  'm5-p5': {
    title: 'Systemic Steroids in Rheum',
    slides: [
      {
        id: 'rheum-steroids',
        emoji: 'ğŸ§¯',
        title: 'Steroids in Rheum',
        subtitle: 'Bridge therapy, then taper',
        facts: [
          'ğŸ¯ Use: flares (RA, gout, vasculitis) â€” quick symptom control',
          'âš ï¸ AEs: hyperglycemia â€¢ mood â€¢ BPâ†‘ â€¢ fluid retention',
          'âš ï¸ Longâ€‘term: osteoporosis, infection risk, adrenal suppression',
          'âœ¨ Pearl: lowest dose/shortest time; bone protection if long-term',
          'ğŸ” Taper: if prolonged course; donâ€™t stop suddenly',
        ],
      },
    ],
  },

  // =========================
  // Module 6 â€” Infectious Disease
  // =========================
  'm6-p1': {
    title: 'Antibiotic Strategy & Big Buckets',
    slides: [
      {
        id: 'abx-strategy',
        emoji: 'ğŸ§­',
        title: 'Antibiotic Strategy',
        subtitle: 'Start smart, then narrow',
        facts: [
          'ğŸ¯ Goal: treat infection + avoid resistance',
          'ğŸ§ª Culture: get cultures BEFORE antibiotics when possible',
          'ğŸ§­ Empiric: cover likely bugs/site; deâ€‘escalate with results',
          'âš ï¸ Red flags: C. diff diarrhea; allergy history matters',
          'âœ¨ Pearl: shortest effective duration wins',
        ],
      },
    ],
  },

  'm6-p2': {
    title: 'Betaâ€‘Lactams (PCNs, Cephs)',
    slides: [
      {
        id: 'penicillins',
        emoji: 'ğŸ§«',
        title: 'Penicillins + BL/BLI',
        subtitle: 'â€œâ€‘CILLINâ€ antibiotics',
        facts: [
          'ğŸ¯ Use: common infections (strep, otitis, sinusitis, skin)',
          'ğŸ§¬ MOA: cell wall synthesis inhibit (bactericidal)',
          'âš ï¸ AEs: allergy rash â†’ anaphylaxis; diarrhea',
          'âœ¨ BL/BLI: Augmentin, Zosyn broaden Î²â€‘lactamase coverage',
          'ğŸ” Pearl: adjust dose for renal function',
        ],
      },
      {
        id: 'cephalosporins',
        emoji: 'ğŸ§±',
        title: 'Cephalosporins',
        subtitle: 'â€œCEF/CEPHâ€‘â€ antibiotics',
        facts: [
          'ğŸ¯ Use: varies by generation (skin â†’ pneumonia â†’ meningitis)',
          'âœ¨ Examples: cephalexin (skin/UTI), ceftriaxone (pneumonia/meningitis)',
          'âš ï¸ AEs: allergy (crossâ€‘react low), diarrhea',
          'ğŸ§¬ Coverage: later gens â†‘ Gramâ€‘; some cover Pseudomonas',
          'ğŸ” Pearl: ceftriaxone can cause biliary sludging (rare)',
        ],
      },
    ],
  },

  'm6-p3': {
    title: 'Macrolides, FQs, Tetracyclines',
    slides: [
      {
        id: 'macrolides',
        emoji: 'ğŸ«',
        title: 'Macrolides',
        subtitle: 'â€œâ€‘THROMYCINâ€ (azithro, clarithro)',
        facts: [
          'ğŸ¯ Use: atypical pneumonia, respiratory infections',
          'ğŸ§¬ MOA: 50S protein synthesis inhibit',
          'âš ï¸ AEs: QT prolongation â€¢ GI upset',
          'âš ï¸ Interactions: clarithro/erythro = strong CYP3A4 inhibitors',
          'âœ¨ Pearl: azithro has fewer interactions',
        ],
      },
      {
        id: 'fluoroquinolones',
        emoji: 'âš ï¸',
        title: 'Fluoroquinolones',
        subtitle: 'â€œâ€‘FLOXACINâ€ (cipro, levo)',
        facts: [
          'ğŸ¯ Use: complicated UTI/pyelo, some pneumonia (levo)',
          'ğŸ§¬ MOA: DNA gyrase/topoisomerase inhibit',
          'âš ï¸ Boxed: tendon rupture, neuropathy, CNS effects',
          'ğŸš« Avoid: pregnancy/kids; caution QT issues',
          'âœ¨ Pearl: chelates â€” separate from Ca/Fe/antacids',
        ],
      },
      {
        id: 'tetracyclines',
        emoji: 'â˜€ï¸',
        title: 'Tetracyclines',
        subtitle: 'â€œâ€‘CYCLINEâ€ (doxycycline)',
        facts: [
          'ğŸ¯ Use: acne, Lyme, atypical pneumonia, MRSA skin',
          'ğŸ§¬ MOA: 30S protein synthesis inhibit',
          'âš ï¸ AEs: photosensitivity â€¢ GI â€¢ esophagitis',
          'ğŸš« Avoid: pregnancy & kids (teeth/bone discoloration)',
          'âœ¨ Pearl: take with water; stay upright; avoid dairy/antacids',
        ],
      },
    ],
  },

  'm6-p4': {
    title: 'Sulfonamides & Others',
    slides: [
      {
        id: 'uti-workhorses',
        emoji: 'ğŸš½',
        title: 'UTI Workhorses',
        subtitle: 'TMP/SMX & nitrofurantoin',
        facts: [
          'ğŸ¯ TMP/SMX use: UTI, MRSA skin, Pneumocystis',
          'âš ï¸ TMP/SMX AEs: rash/SJS, hyperK, kidney effects; sulfa allergy',
          'ğŸ¯ Nitrofurantoin: uncomplicated cystitis only',
          'âš ï¸ Nitrofurantoin: lung/hepatic toxicity (rare); avoid if low CrCl',
          'âœ¨ Pearl: nitrofurantoin doesnâ€™t treat pyelonephritis',
        ],
      },
      {
        id: 'metronidazole',
        emoji: 'ğŸš«',
        title: 'Metronidazole',
        subtitle: 'FLAGYL for anaerobes',
        facts: [
          'ğŸ¯ Use: anaerobes (intraâ€‘abdominal), BV, giardia',
          'ğŸ§¬ MOA: DNA damage in anaerobes',
          'âš ï¸ AEs: metallic taste â€¢ GI upset â€¢ neuropathy (long-term)',
          'ğŸš« No alcohol: disulfiramâ€‘like reaction',
          'âœ¨ Pearl: â€œbelow diaphragmâ€ anaerobe coverage',
        ],
      },
      {
        id: 'vanc-linezolid',
        emoji: 'ğŸ›¡ï¸',
        title: 'Serious Gram+ Agents',
        subtitle: 'Vancomycin & linezolid',
        facts: [
          'ğŸ¯ Use: MRSA, severe Gram+ infections',
          'ğŸ§¬ Vanc: binds Dâ€‘Alaâ€‘Dâ€‘Ala (cell wall)',
          'âš ï¸ Vanc AEs: nephrotoxicity; â€œred manâ€ infusion reaction',
          'ğŸ§¬ Linezolid: 50S inhibit; great oral bioavailability',
          'âš ï¸ Linezolid: thrombocytopenia; serotonin syndrome with SSRIs',
        ],
      },
    ],
  },

  'm6-p5': {
    title: 'Antifungals & Antivirals',
    slides: [
      {
        id: 'azoles',
        emoji: 'ğŸ„',
        title: 'Azoles',
        subtitle: 'All azoles end in -AZOLE',
        facts: [
          'ğŸ¯ Use: candida (thrush, vaginitis); crypto (fluconazole)',
          'ğŸ§¬ MOA: blocks ergosterol synthesis',
          'âš ï¸ AEs: hepatotoxicity; QT prolongation',
          'âš ï¸ Interactions: CYP inhibition (varies)',
          'âœ¨ Pearl: check LFTs with prolonged therapy',
        ],
      },
      {
        id: 'nystatin',
        emoji: 'ğŸ‘…',
        title: 'Nystatin',
        subtitle: 'Topical for thrush',
        facts: [
          'ğŸ¯ Use: oral candidiasis (swish & swallow/spit)',
          'ğŸ§¬ MOA: binds ergosterol â†’ membrane leak',
          'âœ¨ Pearl: minimal systemic absorption (safe)',
          'âš ï¸ AEs: mild GI upset; bad taste',
          'ğŸš« Not for: systemic fungal infections',
        ],
      },
      {
        id: 'antivirals',
        emoji: 'ğŸ§Š',
        title: 'Acyclovir / Oseltamivir',
        subtitle: 'HSV/VZV vs influenza',
        facts: [
          'ğŸ¯ Acyclovir/valacyclovir: HSV, shingles',
          'ğŸ§¬ MOA: inhibits viral DNA polymerase (after activation)',
          'âš ï¸ AEs: kidney crystals â†’ hydrate; neurotoxicity (rare)',
          'ğŸ¯ Oseltamivir: influenza (best within 48 hrs)',
          'âš ï¸ Oseltamivir: nausea/vomiting; neuropsychiatric (rare)',
        ],
      },
    ],
  },

  // =========================
  // Module 7 â€” Respiratory & Allergy
  // =========================
  'm7-p1': {
    title: 'Asthma/COPD Overview (Stepwise Logic)',
    slides: [
      {
        id: 'asthma-overview',
        emoji: 'ğŸŒ¬ï¸',
        title: 'Asthma/COPD Quick Logic',
        subtitle: 'Rescue vs controller',
        facts: [
          'ğŸ¯ Rescue: SABA for quick relief (albuterol)',
          'ğŸ›¡ï¸ Controller: ICS is foundation for persistent asthma',
          'ğŸ§­ Step up: add LABA/LAMA/other controllers as needed',
          'âš ï¸ Red flag: frequent SABA use = poor control',
          'âœ¨ Pearl: COPD = bronchodilators first; ICS for frequent exacerbations',
        ],
      },
    ],
  },

  'm7-p2': {
    title: 'Inhaled Bronchodilators (SABA, LABA, LAMA)',
    slides: [
      {
        id: 'beta-agonists',
        emoji: 'ğŸ’¨',
        title: 'Betaâ€‘Agonists',
        subtitle: 'LABAs often end in -TEROL',
        facts: [
          'ğŸ¯ SABA (albuterol): rescue bronchodilator',
          'ğŸ¯ LABA (salmeterol/formoterol): maintenance (with controller)',
          'ğŸ§¬ MOA: Î²2 agonist â†’ bronchodilation',
          'âš ï¸ AEs: tremor â€¢ tachycardia â€¢ hypokalemia (rare)',
          'ğŸš« Asthma: LABA should NOT be used without ICS',
        ],
      },
      {
        id: 'antimuscarinics',
        emoji: 'ğŸšª',
        title: 'Antimuscarinics',
        subtitle: 'â€œâ€‘TROPIUMâ€ (ipratropium/tiotropium)',
        facts: [
          'ğŸ¯ Use: COPD maintenance (LAMA); addâ€‘on in asthma (some)',
          'ğŸ§¬ MOA: blocks muscarinic receptors â†’ bronchodilation',
          'âš ï¸ AEs: dry mouth â€¢ urinary retention â€¢ glaucoma caution',
          'âœ¨ Pearl: tiotropium = once daily',
          'ğŸš« Avoid: spray in eyes; caution severe BPH',
        ],
      },
    ],
  },

  'm7-p3': {
    title: 'Inhaled Corticosteroids & Combos',
    slides: [
      {
        id: 'ics',
        emoji: 'ğŸ›¡ï¸',
        title: 'ICS',
        subtitle: 'Controller therapy',
        facts: [
          'ğŸ¯ Use: persistent asthma (reduces exacerbations)',
          'ğŸ§¬ MOA: airway inflammationâ†“',
          'âš ï¸ AEs: thrush â€¢ hoarseness',
          'âœ¨ Pearl: rinse mouth after use; spacer helps',
          'ğŸš« Not rescue: doesnâ€™t work immediately for acute symptoms',
        ],
      },
      {
        id: 'combo-inhalers',
        emoji: 'ğŸ§©',
        title: 'Combo Inhalers',
        subtitle: 'ICS/LABA (Advair, Symbicort)',
        facts: [
          'ğŸ¯ Use: moderateâ€‘severe asthma; COPD with exacerbations',
          'ğŸ§¬ Combos: ICS + LABA (sometimes + LAMA in COPD)',
          'âœ¨ SMART: budesonide/formoterol can be maintenance + rescue (select)',
          'âš ï¸ Watch: ICS thrush + LABA tremor/tachy',
          'ğŸ” Pearl: teach inhaler technique (biggest â€œdoseâ€ factor)',
        ],
      },
    ],
  },

  'm7-p4': {
    title: 'Leukotriene Modifiers & Controllers',
    slides: [
      {
        id: 'montelukast',
        emoji: 'ğŸŒ¿',
        title: 'Montelukast',
        subtitle: 'Oral controller (modest benefit)',
        facts: [
          'ğŸ¯ Use: allergic rhinitis + asthma addâ€‘on; exercise asthma',
          'ğŸ§¬ MOA: leukotriene receptor antagonist',
          'âš ï¸ Warning: neuropsychiatric effects (mood, dreams)',
          'âœ¨ Pearl: convenient oral option; best for allergy overlap',
          'ğŸš« Caution: depression/anxiety history',
        ],
      },
      {
        id: 'theophylline',
        emoji: 'â˜•',
        title: 'Theophylline',
        subtitle: 'Narrow therapeutic index',
        facts: [
          'ğŸ¯ Use: rare now; COPD/asthma addâ€‘on',
          'ğŸ§¬ MOA: PDE inhibition â†’ bronchodilation',
          'âš ï¸ Toxicity: nausea, arrhythmias, seizures',
          'âš ï¸ Interactions: CYP metabolism (many drug interactions)',
          'ğŸ” Monitor: serum levels if used',
        ],
      },
    ],
  },

  'm7-p5': {
    title: 'Antihistamines & Nasal Steroids',
    slides: [
      {
        id: 'antihistamines',
        emoji: 'ğŸŒ¸',
        title: 'Antihistamines',
        subtitle: 'Allergy symptom relief',
        facts: [
          'ğŸ¯ 2nd gen: cetirizine/loratadine/fexofenadine (less sedation)',
          'ğŸ¯ 1st gen: diphenhydramine (very sedating)',
          'âš ï¸ 1st gen AEs: anticholinergic (dry mouth, urinary retention)',
          'âœ¨ Pearl: avoid diphenhydramine in older adults (falls/delirium)',
          'ğŸ” Use: itching/sneezing; not great for congestion alone',
        ],
      },
      {
        id: 'nasal-steroids',
        emoji: 'ğŸŒ¬ï¸',
        title: 'Intranasal Steroids',
        subtitle: 'Best for congestion control',
        facts: [
          'ğŸ¯ Use: allergic rhinitis (daily = best effect)',
          'ğŸ§¬ MOA: local inflammationâ†“',
          'âš ï¸ AEs: nose irritation/epistaxis',
          'âœ¨ Pearl: aim spray away from septum to reduce bleeding',
          'ğŸš« Not instant: takes days for full effect',
        ],
      },
    ],
  },

  // =========================
  // Module 8 â€” GI & Hepatic
  // =========================
  'm8-p1': {
    title: 'Acid Suppression (PPIs, H2 Blockers)',
    slides: [
      {
        id: 'ppis',
        emoji: 'ğŸ”¥',
        title: 'PPIs',
        subtitle: 'All PPIs end in -PRAZOLE',
        facts: [
          'ğŸ¯ Use: GERD, ulcers, GI bleed prophylaxis (high risk)',
          'ğŸ§¬ MOA: irreversibly blocks proton pump',
          'âš ï¸ Longâ€‘term: C. diff, low Mg, fractures, B12 low (association)',
          'âœ¨ Pearl: take before meals; strongest acid control',
          'ğŸš« Interaction: omeprazole can reduce clopidogrel activation',
        ],
      },
      {
        id: 'h2-blockers',
        emoji: 'ğŸ§Š',
        title: 'H2 Blockers',
        subtitle: 'Most end in -TIDINE',
        facts: [
          'ğŸ¯ Use: mild GERD, nocturnal symptoms',
          'ğŸ§¬ MOA: blocks histamine H2 receptors on parietal cells',
          'âš ï¸ AEs: confusion (elderly), B12 low (long-term)',
          'âœ¨ Pearl: tolerance can develop with continuous use',
          'ğŸ” Dose: renal adjust (famotidine)',
        ],
      },
    ],
  },

  'm8-p2': {
    title: 'Antiemetics',
    slides: [
      {
        id: 'ondansetron',
        emoji: 'ğŸ¤¢',
        title: 'Ondansetron',
        subtitle: 'â€œâ€‘SETRONâ€ = 5â€‘HT3 blocker',
        facts: [
          'ğŸ¯ Use: chemo/postâ€‘op nausea, gastroenteritis',
          'ğŸ§¬ MOA: blocks serotonin 5â€‘HT3 receptors',
          'âš ï¸ AEs: constipation â€¢ headache',
          'âš ï¸ QT: risk â†‘ with high dose/other QT meds',
          'âœ¨ Pearl: great â€œgoâ€‘toâ€ for many patients',
        ],
      },
      {
        id: 'other-antiemetics',
        emoji: 'ğŸŒ€',
        title: 'Other Antiemetics',
        subtitle: 'Metoclopramide / Promethazine / Scopolamine',
        facts: [
          'ğŸ¯ Metoclopramide: gastroparesis + nausea',
          'âš ï¸ Metoclopramide: EPS/tardive dyskinesia risk',
          'ğŸ¯ Promethazine: very sedating (antihistamine)',
          'ğŸ¯ Scopolamine patch: motion sickness',
          'ğŸš« Caution: sedation + anticholinergic effects (older adults)',
        ],
      },
    ],
  },

  'm8-p3': {
    title: 'Laxatives & Antidiarrheals',
    slides: [
      {
        id: 'constipation',
        emoji: 'ğŸš½',
        title: 'Constipation Toolbox',
        subtitle: 'Pick by speed + cause',
        facts: [
          'ğŸ¯ Osmotic: PEG (Miralax), lactulose â†’ water in stool',
          'ğŸ¯ Stimulant: senna, bisacodyl â†’ motilityâ†‘',
          'ğŸ¯ Softener: docusate (weak evidence)',
          'âš ï¸ AEs: diarrhea/cramps; lactulose = gas',
          'âœ¨ Pearl: opioids â†’ stimulant + osmotic often needed',
        ],
      },
      {
        id: 'antidiarrheal',
        emoji: 'ğŸ§»',
        title: 'Antidiarrheals',
        subtitle: 'Loperamide = â€œgut opioidâ€',
        facts: [
          'ğŸ¯ Use: symptomatic diarrhea (nonâ€‘infectious)',
          'ğŸ§¬ MOA: Î¼â€‘receptor in gut â†’ motilityâ†“',
          'âš ï¸ Danger: high doses â†’ serious arrhythmias',
          'ğŸš« Avoid: bloody diarrhea, high fever, suspected C. diff',
          'âœ¨ Pearl: oral rehydration is mainstay',
        ],
      },
    ],
  },

  'm8-p4': {
    title: 'Antispasmodics',
    slides: [
      {
        id: 'antispasmodics',
        emoji: 'ğŸ«§',
        title: 'Antispasmodics (IBS)',
        subtitle: 'Dicyclomine / Hyoscyamine',
        facts: [
          'ğŸ¯ Use: IBS cramps/spasm relief',
          'ğŸ§¬ MOA: anticholinergic â†’ smooth muscle relaxation',
          'âš ï¸ AEs: dry mouth â€¢ constipation â€¢ blurry vision â€¢ urinary retention',
          'ğŸš« Avoid: glaucoma, severe BPH, myasthenia gravis',
          'âœ¨ Pearl: â€œas neededâ€ before meals works well',
        ],
      },
    ],
  },

  'm8-p5': {
    title: 'IBD & Liverâ€‘Related Drugs',
    slides: [
      {
        id: 'mesalamine',
        emoji: 'ğŸ§»',
        title: 'Mesalamine (5â€‘ASA)',
        subtitle: 'Ulcerative colitis workhorse',
        facts: [
          'ğŸ¯ Use: mildâ€‘moderate ulcerative colitis',
          'ğŸ§¬ MOA: local antiâ€‘inflammatory in colon',
          'âš ï¸ AEs: headache, nausea; rare kidney injury',
          'âœ¨ Pearl: different formulations target different GI sites',
          'ğŸ” Monitor: renal function (periodic)',
        ],
      },
      {
        id: 'infliximab',
        emoji: 'ğŸ›¡ï¸',
        title: 'Infliximab (Biologic)',
        subtitle: 'TNFâ€‘Î± inhibitor for moderateâ€‘severe IBD',
        facts: [
          'ğŸ¯ Use: Crohnâ€™s/UC refractory; also RA',
          'ğŸ§¬ MOA: blocks TNFâ€‘Î±',
          'âš ï¸ AEs: serious infections; infusion reactions',
          'ğŸ” Screen: TB + hepatitis before starting',
          'ğŸš« Avoid: live vaccines; caution HF',
        ],
      },
      {
        id: 'rifaximin-ursodiol',
        emoji: 'ğŸ§©',
        title: 'Liver/Gut Pearls',
        subtitle: 'Rifaximin & ursodiol',
        facts: [
          'ğŸ¯ Rifaximin: travelerâ€™s diarrhea; hepatic encephalopathy prevention',
          'âœ¨ Pearl: minimal absorption â†’ fewer systemic effects',
          'ğŸ¯ Ursodiol: dissolves cholesterol stones; treats PBC',
          'âš ï¸ AEs: GI upset; slow effect',
          'ğŸ” Pearl: these are â€œniche but highâ€‘yieldâ€ meds',
        ],
      },
    ],
  },

  // =========================
  // Module 9 â€” Neuro & Seizures
  // =========================
  'm9-p1': {
    title: 'Seizure Meds Overview',
    slides: [
      {
        id: 'aed-overview',
        emoji: 'âš¡',
        title: 'AED Big Picture',
        subtitle: 'Control vs toxicity balance',
        facts: [
          'ğŸ¯ Goal: seizure freedom with minimal side effects',
          'ğŸ” Monitor: mood, cognition, rash, liver/blood counts (drugâ€‘dependent)',
          'âš ï¸ Pregnancy: some AEDs teratogenic (valproate high risk)',
          'âœ¨ Pearl: adherence is key; missed doses = breakthrough seizures',
          'ğŸš« Donâ€™t: stop AEDs abruptly (rebound seizures)',
        ],
      },
    ],
  },

  'm9-p2': {
    title: 'Classic Antiepileptics',
    slides: [
      {
        id: 'phenytoin',
        emoji: 'âš¡',
        title: 'Phenytoin',
        subtitle: 'â€œPHYNYâ€ = gums + nystagmus',
        facts: [
          'ğŸ¯ Use: focal seizures; status epilepticus (after benzo)',
          'âš ï¸ AEs: nystagmus, ataxia, sedation',
          'âš ï¸ Chronic: gingival hyperplasia, hirsutism, osteopenia',
          'ğŸ§¬ CYP inducer: many drug interactions',
          'âœ¨ Pearl: narrow TI; levels help in toxicity/nonadherence',
        ],
      },
      {
        id: 'valproate',
        emoji: 'ğŸ§¯',
        title: 'Valproate',
        subtitle: 'Broad spectrum but teratogenic',
        facts: [
          'ğŸ¯ Use: generalized seizures; bipolar; migraine prevention',
          'âš ï¸ AEs: weight gain, tremor, hair loss',
          'âš ï¸ Serious: hepatotoxicity, pancreatitis, thrombocytopenia',
          'ğŸš« Avoid: pregnancy (neural tube defects)',
          'ğŸ” Monitor: LFTs, platelets; ammonia if encephalopathy',
        ],
      },
      {
        id: 'carbamazepine',
        emoji: 'ğŸ§©',
        title: 'Carbamazepine',
        subtitle: 'Hyponatremia + rash watch',
        facts: [
          'ğŸ¯ Use: focal seizures; trigeminal neuralgia',
          'âš ï¸ AEs: diplopia/ataxia; hyponatremia (SIADH)',
          'âš ï¸ Serious: agranulocytosis/aplastic anemia (rare)',
          'ğŸš« Rash: SJS/TEN risk (HLAâ€‘B*1502 in some Asian ancestry)',
          'ğŸ§¬ CYP inducer: many drug interactions',
        ],
      },
    ],
  },

  'm9-p3': {
    title: 'Newer Antiepileptics',
    slides: [
      {
        id: 'levetiracetam',
        emoji: 'ğŸ™‚',
        title: 'Levetiracetam',
        subtitle: 'Few interactions (common first choice)',
        facts: [
          'ğŸ¯ Use: focal/generalized seizures; IV option inpatient',
          'âœ¨ Pearl: minimal drug interactions',
          'âš ï¸ AEs: mood/behavior changes (irritability, depression)',
          'ğŸ” Dose: renal adjustment',
          'ğŸš« Counsel: report mood worsening',
        ],
      },
      {
        id: 'lamotrigine',
        emoji: 'ğŸŒ‹',
        title: 'Lamotrigine',
        subtitle: 'Slow titration to avoid rash',
        facts: [
          'ğŸ¯ Use: seizures + bipolar maintenance',
          'âš ï¸ Rash: SJS/TEN risk (fast titration â†‘ risk)',
          'âœ¨ Pearl: â€œstart low, go slowâ€',
          'ğŸ§¬ Interaction: valproate â†‘ lamotrigine levels',
          'ğŸš« Stop: any serious rash needs urgent evaluation',
        ],
      },
      {
        id: 'other-aeds',
        emoji: 'ğŸ§ ',
        title: 'Other Highâ€‘Yield AEDs',
        subtitle: 'Topiramate + gabapentinoids',
        facts: [
          'ğŸ¯ Topiramate: seizures + migraine prevention',
          'âš ï¸ Topiramate: cognitive slowing, paresthesias, kidney stones',
          'ğŸ¯ Gabapentin/pregabalin: neuropathic pain + adjunct seizures',
          'âš ï¸ Gabapentinoids: sedation, dizziness, edema',
          'ğŸ” Pearl: renal dose adjust; avoid excess CNS depressants',
        ],
      },
    ],
  },

  'm9-p4': {
    title: 'Migraine Acute & Preventive',
    slides: [
      {
        id: 'triptans',
        emoji: 'ğŸŒ©ï¸',
        title: 'Triptans (Acute)',
        subtitle: 'Most end in -TRIPTAN',
        facts: [
          'ğŸ¯ Use: acute migraine (best early)',
          'ğŸ§¬ MOA: 5â€‘HT1 agonist â†’ vasoconstriction + neuropeptidesâ†“',
          'ğŸš« Avoid: CAD, stroke/TIA, uncontrolled HTN',
          'âš ï¸ AEs: chest tightness, flushing; serotonin syndrome (rare)',
          'âœ¨ Pearl: limit use to avoid medication overuse headache',
        ],
      },
      {
        id: 'prevention',
        emoji: 'ğŸ›¡ï¸',
        title: 'Prevention',
        subtitle: 'CGRP mAbs + classic options',
        facts: [
          'ğŸ¯ CGRP mAbs (erenumab): monthly prevention',
          'âš ï¸ CGRP AEs: constipation, injection reactions',
          'ğŸ¯ Others: propranolol, topiramate, valproate',
          'âœ¨ Pearl: choose based on comorbidities (HTN, obesity, depression)',
          'ğŸ” Goal: fewer attacks + less disability',
        ],
      },
    ],
  },

  'm9-p5': {
    title: 'Parkinsonâ€™s Disease Medications',
    slides: [
      {
        id: 'levodopa',
        emoji: 'ğŸ§ ',
        title: 'Levodopa/Carbidopa',
        subtitle: 'Best symptom control',
        facts: [
          'ğŸ¯ Use: improves bradykinesia/rigidity',
          'ğŸ§¬ MOA: levodopa â†’ dopamine; carbidopa â†“ peripheral conversion',
          'âš ï¸ AEs: nausea, orthostasis, hallucinations',
          'âš ï¸ Longâ€‘term: dyskinesias, â€œon/offâ€ fluctuations',
          'âœ¨ Pearl: highâ€‘protein meals can reduce absorption',
        ],
      },
      {
        id: 'adjuncts',
        emoji: 'âš™ï¸',
        title: 'Adjunct Options',
        subtitle: 'DA agonists & MAOâ€‘B inhibitors',
        facts: [
          'ğŸ¯ DA agonists: pramipexole/ropinirole (younger pts)',
          'âš ï¸ DA agonists: impulse control, sleep attacks, edema',
          'ğŸ¯ MAOâ€‘B inhibitors: rasagiline (modest addâ€‘on benefit)',
          'âš ï¸ AEs: insomnia; interactions (serotonin syndrome risk with some)',
          'âœ¨ Pearl: hallucinations more common in older adults',
        ],
      },
    ],
  },

  // =========================
  // Module 10 â€” GU & Miscellaneous
  // =========================
  'm10-p1': {
    title: 'BPH & Overactive Bladder',
    slides: [
      {
        id: 'bph',
        emoji: 'ğŸš½',
        title: 'BPH Meds',
        subtitle: 'Alphaâ€‘1 blockers vs 5â€‘ARI',
        facts: [
          'ğŸ¯ Alphaâ€‘1 blockers: tamsulosin (fast symptom relief)',
          'ğŸ§¬ MOA: relax prostate/bladder neck â†’ flowâ†‘',
          'âš ï¸ AEs: dizziness/orthostasis; ejaculatory issues',
          'ğŸ¯ Finasteride: shrinks prostate (slow onset months)',
          'âœ¨ Pearl: finasteride lowers PSA (~50%); sexual SEs',
        ],
      },
      {
        id: 'oab',
        emoji: 'ğŸ’§',
        title: 'Overactive Bladder',
        subtitle: 'Anticholinergic vs Î²3 agonist',
        facts: [
          'ğŸ¯ Oxybutynin: urgency/frequency control',
          'âš ï¸ Oxybutynin AEs: dry mouth, constipation, confusion (elderly)',
          'ğŸ¯ Mirabegron: Î²3 agonist (less anticholinergic)',
          'âš ï¸ Mirabegron: can raise BP',
          'âœ¨ Pearl: avoid anticholinergics in older adults when possible',
        ],
      },
    ],
  },

  'm10-p2': {
    title: 'Osteoporosis & Bone Health',
    slides: [
      {
        id: 'bisphosphonates',
        emoji: 'ğŸ¦´',
        title: 'Bisphosphonates',
        subtitle: 'Most end in -DRONATE',
        facts: [
          'ğŸ¯ Use: osteoporosis firstâ€‘line (alendronate, zoledronic acid)',
          'ğŸ§¬ MOA: osteoclast activityâ†“ â†’ bone resorptionâ†“',
          'âš ï¸ AEs: esophagitis (oral); fluâ€‘like (IV); hypocalcemia',
          'âœ¨ Pearl: take oral AM with water; stay upright 30 min',
          'âš ï¸ Rare: osteonecrosis jaw, atypical femur fracture',
        ],
      },
      {
        id: 'other-bone',
        emoji: 'ğŸ›¡ï¸',
        title: 'Other Options',
        subtitle: 'Denosumab & SERMs',
        facts: [
          'ğŸ¯ Denosumab: RANKL inhibitor; SC q6 months',
          'âš ï¸ Denosumab: hypocalcemia/infections; rebound if stopped',
          'ğŸ¯ Raloxifene: spine fractureâ†“; breast CA riskâ†“',
          'âš ï¸ Raloxifene: VTE risk; hot flashes',
          'âœ¨ Pearl: ensure Ca/Vit D + weightâ€‘bearing exercise',
        ],
      },
    ],
  },

  'm10-p3': {
    title: 'Contraceptives & Hormonal Therapy',
    slides: [
      {
        id: 'combined-contraception',
        emoji: 'ğŸ§¬',
        title: 'Combined Contraceptives',
        subtitle: 'Estrogen + progestin',
        facts: [
          'ğŸ¯ Use: pregnancy prevention; acne; cycle control',
          'ğŸ§¬ MOA: suppress ovulation + thicken cervical mucus',
          'âš ï¸ AEs: nausea, breast tenderness; BPâ†‘',
          'ğŸš« Contra: VTE hx, migraine w/aura, smokers >35',
          'âœ¨ Pearl: missed pills = follow a plan; backup may be needed',
        ],
      },
      {
        id: 'progestin-hrt',
        emoji: 'ğŸŒ¸',
        title: 'Progestin/Hormone Therapy',
        subtitle: 'Medroxyprogesterone + estrogens',
        facts: [
          'ğŸ¯ Progestinâ€‘only: option when estrogen contraindicated',
          'âš ï¸ Depot medroxyprogesterone: weight gain; bone densityâ†“',
          'ğŸ¯ HRT: menopausal symptoms (lowest dose, shortest time)',
          'âš ï¸ HRT risks: VTE, stroke; add progestin if uterus present',
          'âœ¨ Pearl: personalize based on symptom severity + risk factors',
        ],
      },
    ],
  },

  'm10-p4': {
    title: 'Smoking Cessation & Dependence',
    slides: [
      {
        id: 'varenicline',
        emoji: 'ğŸš­',
        title: 'Varenicline',
        subtitle: 'Partial nicotine agonist',
        facts: [
          'ğŸ¯ Use: top singleâ€‘agent quit aid for many',
          'ğŸ§¬ MOA: partial agonist at nicotinic receptor â†’ cravingsâ†“',
          'âš ï¸ AEs: nausea, vivid dreams, insomnia',
          'âš ï¸ Mood: monitor depression/suicidality in vulnerable patients',
          'âœ¨ Pearl: set quit date; start ~1 week prior',
        ],
      },
      {
        id: 'nrt-bupropion',
        emoji: 'ğŸ§©',
        title: 'Other Quit Aids',
        subtitle: 'NRT + bupropion',
        facts: [
          'ğŸ¯ NRT: patch (steady) + gum/lozenge (cravings)',
          'âš ï¸ NRT AEs: skin irritation (patch); mouth irritation (gum)',
          'ğŸ¯ Bupropion: helps cravings; great if depression present',
          'âš ï¸ Bupropion: seizure risk; insomnia',
          'âœ¨ Pearl: meds + counseling = highest success',
        ],
      },
    ],
  },

  'm10-p5': {
    title: 'Eye/Ear & Misc Top 300 Drugs',
    slides: [
      {
        id: 'glaucoma',
        emoji: 'ğŸ‘ï¸',
        title: 'Glaucoma Drops',
        subtitle: 'Latanoprost & timolol',
        facts: [
          'ğŸ¯ Latanoprost: firstâ€‘line openâ€‘angle glaucoma',
          'ğŸ§¬ MOA: â†‘ uveoscleral outflow (prostaglandin analog)',
          'âš ï¸ AEs: iris darkening, eyelash growth, eye redness',
          'ğŸ¯ Timolol: Î²â€‘blocker drop â†’ aqueous humorâ†“',
          'ğŸš« Caution: asthma/COPD or bradycardia (systemic absorption)',
        ],
      },
      {
        id: 'ciprodex',
        emoji: 'ğŸ‘‚',
        title: 'Ear Drops',
        subtitle: 'Ciprodex = antibiotic + steroid',
        facts: [
          'ğŸ¯ Use: otitis externa; otitis media w/tubes',
          'ğŸ§¬ Ciprofloxacin kills bacteria; dexamethasone inflammationâ†“',
          'âœ¨ Pearl: warm bottle in hands before instillation (comfort)',
          'âœ¨ Technique: tragus pump; stay sideâ€‘lying a few minutes',
          'ğŸš« Avoid: unknown perforation unless approved formulation',
        ],
      },
      {
        id: 'renal-misc',
        emoji: 'ğŸ©¸',
        title: 'Renal/Anemia Pearls',
        subtitle: 'Sevelamer & epoetin alfa',
        facts: [
          'ğŸ¯ Sevelamer: phosphate binder in CKD (take with meals)',
          'âš ï¸ Sevelamer: GI upset; can bind other meds',
          'ğŸ¯ Epoetin alfa: CKD anemia (stimulates RBC production)',
          'âš ï¸ Risks: HTN, thrombosis if Hb pushed too high',
          'ğŸ” Monitor: Hb/iron; ensure iron stores adequate',
        ],
      },
    ],
  },
};

export function getTeachingDeckForPart(partId: string): TeachingSlideDeck | null {
  return TEACHING_DECKS[partId] ?? null;
}
